GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nortech Systems Inc (NAS:NSYS) » Definitions » ROE %
中文

Nortech Systems (Nortech Systems) ROE %

: 52.71% (As of Dec. 2023)
View and export this data going back to 1993. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Nortech Systems's annualized net income for the quarter that ended in Dec. 2023 was $17.4 Mil. Nortech Systems's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $33.0 Mil. Therefore, Nortech Systems's annualized ROE % for the quarter that ended in Dec. 2023 was 52.71%.

The historical rank and industry rank for Nortech Systems's ROE % or its related term are showing as below:

NSYS' s ROE % Range Over the Past 10 Years
Min: -11.61   Med: 0.51   Max: 31.92
Current: 22.53

During the past 13 years, Nortech Systems's highest ROE % was 31.92%. The lowest was -11.61%. And the median was 0.51%.

NSYS's ROE % is ranked better than
93.83% of 811 companies
in the Medical Devices & Instruments industry
Industry Median: 0.25 vs NSYS: 22.53

Nortech Systems ROE % Historical Data

The historical data trend for Nortech Systems's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortech Systems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.98 -7.99 31.92 7.42 21.68

Nortech Systems Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.42 9.56 8.69 16.04 52.71

Competitive Comparison

For the Medical Devices subindustry, Nortech Systems's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nortech Systems ROE % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Nortech Systems's ROE % distribution charts can be found below:

* The bar in red indicates where Nortech Systems's ROE % falls into.



Nortech Systems ROE % Calculation

Nortech Systems's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=6.874/( (28.08+35.344)/ 2 )
=6.874/31.712
=21.68 %

Nortech Systems's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=17.408/( (30.708+35.344)/ 2 )
=17.408/33.026
=52.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Nortech Systems  (NAS:NSYS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=17.408/33.026
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(17.408 / 144.216)*(144.216 / 70.557)*(70.557 / 33.026)
=Net Margin %*Asset Turnover*Equity Multiplier
=12.07 %*2.044*2.1364
=ROA %*Equity Multiplier
=24.67 %*2.1364
=52.71 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=17.408/33.026
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (17.408 / 10.22) * (10.22 / 10.708) * (10.708 / 144.216) * (144.216 / 70.557) * (70.557 / 33.026)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.7033 * 0.9544 * 7.42 % * 2.044 * 2.1364
=52.71 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Nortech Systems ROE % Related Terms

Thank you for viewing the detailed overview of Nortech Systems's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortech Systems (Nortech Systems) Business Description

Traded in Other Exchanges
N/A
Address
7550 Meridian Circle N, Suite 150, Maple Grove, MN, USA, 55369
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical and manufacturing services and support including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense and Industrial markets with key revenue coming from Medical device and product manufacturing and related engineering services.
Executives
Amy S. Fredregill director 7550 MERIDIAN CIRCLE N., SUITE # 150, MAPLE GROVE MN 55369
Jose Antonio Peris director 7550 MERIDIAN CIRCLE N., SUITE # 150, MAPLE GROVE MN 55369
David B Kunin director 7201 METRO BOULEVARD, MINNEAPOLIS MN 55439
David J. Graff director 7550 MERIDIAN CIRCLE N., SUITE 150, MAPLE GROVE MN 55369
Daniel Ramon Everingham 10 percent owner 617 COUNTRY VIEW LANE, GARLAND TX 75043
Jay D Miller director 7550 MERIDIAN CIR N, SUITE 150, MAPLE GROVE MN 55369
Christopher Dean Jones officer: CFO 7550 MERIDIAN CIRCLE N., SUITE 150, MAPLE GROVE MN 55369
Stacy A Kruse director 7401 BOONE AVENUE NORTH, BROOKLYN PARK MN 55428
Philip Irving Smith director 4503 BROWNDALE AVENUE, EDINA MN 55424
Dan Sachs director 7550 MERIDIAN CIRCLE N., MAPLE GROVE MN 55369
Steven J Rosenstone director 7550 MERIDIAN CIR N, SUITE 150, MAPLE GROVE MN 55369
Heidi B Grange officer: Senior Vice President of HR 7550 MERIDIAN CIRCLE N, MAPLE GROVE MN 55369
John Lindeen officer: Sr VP - Global Operations 7550 MERIDIAN CIRCLE N, SUITE 150, MAPLE GROVE MN 55369
Beck Constance officer: Chief Financial Officer NORTECH SYSTEMS INCORPORATED, 7550 MERDIAN CIRCLE N, MAPLE GROVE MN 55369
Matt Mahmood officer: Chief Operating Officer 7550 MERIDIAN CIRCLE N, SUITE 150, MAPLE GROVE MN 55369

Nortech Systems (Nortech Systems) Headlines